Efficacy and Safety of Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus with Chronic Kidney Disease
Selection of oral antidiabetic drugs (OAD) in patients with type 2 diabetes mellitus (T2DM) with chronic kidney disease (CKD) is very important because most OAD is secreted through the kidneys so dose adjustment is required. In Indonesia, short acting sulfonylureas (SU) are commonly used for the man...
Saved in:
| Main Authors: | Retta C Sihotang, Rizka Ramadhani, Dicky L Tahapary |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Department of Internal Medicine, Faculty of Medicine Universitas Indonesia
2018-09-01
|
| Series: | Jurnal Penyakit Dalam Indonesia |
| Subjects: | |
| Online Access: | http://jurnalpenyakitdalam.ui.ac.id/index.php/jpdi/article/view/202/164 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of sulfonylureas on diverse ion channels: an alternative explanation for the antidiabetic actions
by: Xian-Tao Li, et al.
Published: (2025-06-01) -
Using Pharmacoepidemiology to Examine the Interplay of Sulfonylureas and Infection Risk in Patients With Diabetes Mellitus
by: Yu‐ying Wu, et al.
Published: (2025-04-01) -
Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta‐analysis
by: Kansak Boonpattharatthiti, et al.
Published: (2024-11-01) -
Myricetin Amplifies Glucose–Stimulated Insulin Secretion via the cAMP-PKA-Epac-2 Signaling Cascade
by: Akhtar Ali, et al.
Published: (2025-06-01) -
Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
by: Azeez Taoreed Adegoke, et al.
Published: (2021-08-01)